NEUROCRINE BIOSCIENCES INC Stockholders Equity

Quick Answer

NEUROCRINE BIOSCIENCES INC reported Stockholders Equity of $3.25 billion for the year ending 2025.

  • NEUROCRINE BIOSCIENCES INC showed an increase of +25.6% in Stockholders Equity from 2024 to 2025.
  • This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $144.95 million | Q2 2013: $136.02 million | Q3 2013: $129.29 million | Q1 2014: $247.06 million | Q2 2014: $236.85 million | Q3 2014: $224.04 million | Q1 2015: $484.73 million | Q2 2015: $466.94 million | Q3 2015: $446.94 million | Q1 2016: $412.96 million | Q2 2016: $381.04 million | Q3 2016: $351.65 million | Q1 2017: $247.14 million | Q2 2017: $345.24 million | Q3 2017: $347.51 million | Q1 2018: $364.49 million | Q2 2018: $377.44 million | Q3 2018: $447.51 million | Q1 2019: $409.30 million | Q2 2019: $483.70 million | Q3 2019: $574.50 million | Q1 2020: $700.30 million | Q2 2020: $831.20 million | Q3 2020: $804.30 million | Q1 2021: $1.21 billion | Q2 2021: $1.28 billion | Q3 2021: $1.35 billion | Q1 2022: $1.39 billion | Q2 2022: $1.42 billion | Q3 2022: $1.54 billion | Q1 2023: $1.68 billion | Q2 2023: $1.85 billion | Q3 2023: $2.00 billion | Q1 2024: $2.39 billion | Q2 2024: $2.51 billion | Q3 2024: $2.72 billion | Q1 2025: $2.54 billion | Q2 2025: $2.69 billion | Q3 2025: $3.00 billion.
  • Over the full 14 years of available data (2012 to 2025), NEUROCRINE BIOSCIENCES INC's Stockholders Equity has grown by 2,007.3%.
  • Historical annual values: Fiscal year 2025: $3.25 billion | Fiscal year 2024: $2.59 billion | Fiscal year 2023: $2.23 billion | Fiscal year 2022: $1.71 billion | Fiscal year 2021: $1.37 billion | Fiscal year 2020: $1.13 billion | Fiscal year 2019: $636.90 million | Fiscal year 2018: $480.80 million | Fiscal year 2017: $372.20 million | Fiscal year 2016: $314.88 million | Fiscal year 2015: $424.45 million | Fiscal year 2014: $208.70 million | Fiscal year 2013: $120.41 million | Fiscal year 2012: $154.37 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: